gcfmd Profile Banner
Gregg Fonarow MD Profile
Gregg Fonarow MD

@gcfmd

Followers
12K
Following
25K
Media
2K
Statuses
11K

Los Angeles, CA
Joined December 2012
Don't wanna be here? Send us removal request.
@gcfmd
Gregg Fonarow MD
7 hours
How many clinicians believe having 4 Class 1 guideline-recommended, disease modifying, ☠️⬇️ medical therapies for HFrEF means:. Start 1 or 2 of these therapies and then wait for months/years or till the patient has a HF 🏨 or CV ☠️ before considering starting the other 💊
Tweet media one
Tweet media two
Tweet media three
1
1
11
@gcfmd
Gregg Fonarow MD
1 day
HFrEF. Q-GDMT (ARNI+BB+MRA+SGLT2i). 🛟 Extend median overall survival by 7-11 YEARS. Self-pay cash price all 4 💊. $121 per month. 🎰 Incredible value . ✅ Available now. What is your diagnosis to Q-GDMT time? ⏱️
Tweet media one
5
33
97
@gcfmd
Gregg Fonarow MD
1 day
RT @HFSA: Discover the Depth of Heart Failure Data with HF Stats 📊. HF Stats offers the most up-to-date information on heart failure in the….
0
6
0
@gcfmd
Gregg Fonarow MD
2 days
Comparison of Fixed vs Age-Adjusted NT-proBNP Cutoffs to Define Pre–Heart Failure . JACC @JACCJournals @BiykemB
Tweet media one
Tweet media two
1
15
51
@gcfmd
Gregg Fonarow MD
3 days
“steroidal MRAs have little to no effect on CV mortality in patients requiring dialysis”. Safety and efficacy of steroidal MRAs in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of RCTs - The Lancet
Tweet card summary image
thelancet.com
Our findings suggest that steroidal mineralocorticoid receptor antagonists have little to no effect on cardiovascular mortality in patients requiring dialysis. There is insufficient information on...
0
17
40
@gcfmd
Gregg Fonarow MD
4 days
RT @GiuseppeGalati_: 🔥 #HeartFailure attributed mortality in Europe, 2012–2021. Growing numbers of an epidemic that is now even more deadly….
0
20
0
@gcfmd
Gregg Fonarow MD
5 days
It has proved to be so very difficult to improve CV outcomes in patients receiving maintenance dialysis. Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE) - The Lancet @JavedButler1 @mvaduganathan @AndrewJSauer.
Tweet card summary image
thelancet.com
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared...
0
8
40
@gcfmd
Gregg Fonarow MD
5 days
During the time period that so many effective therapies became available which could prevent incident HF and improve outcomes in prevalent HF…. Why in the US did age-adjusted HF related mortality go up?. Why in European countries did age adjusted HF mortality go up?
Tweet media one
Tweet media two
4
9
27
@gcfmd
Gregg Fonarow MD
6 days
Worldwide red alert🚨. HF attributed ☠️ ⤴️⤴️⤴️. Critical to prioritize prevention and improved treatment of HF globally . Effective evidence-based strategies/therapies exist and are guideline recommended, yet massive implementation gaps, variations, and disparities.
@drbennisahmed
Ahmed Bennis MD 🫀
6 days
Heart failure-attributed mortality in Europe, 2012–2021. Heart failure-attributed mortality in Europe increased between 2012 and 2021. Substantial disparities persist across European regions and countries. @mvaduganathan @gcfmd @SJGreene_md @AndrewJSauer @ankeetbhatt @BiykemB
Tweet media one
1
7
23
@gcfmd
Gregg Fonarow MD
9 days
RT @CircHF: Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score @GCFMD @SJGreene_md #AHAJo….
0
32
0
@gcfmd
Gregg Fonarow MD
10 days
RT @SS_cardiol: Excited to share our editorial, guided by @SJGreene_md & @gcfmd, now out in @CircHF!. A shift in focus for GDMT: It's not j….
0
7
0
@gcfmd
Gregg Fonarow MD
10 days
RT @SJGreene_md: 🏆Simultaneous or Rapid Sequence Initiation of Combination GDMT . GDMT scores to date capture important omissions & underdo….
0
40
0
@gcfmd
Gregg Fonarow MD
11 days
Tweet media one
0
4
7
@gcfmd
Gregg Fonarow MD
12 days
RT @JAMANetworkOpen: #GLP1 receptor agonist use for patients with type 2 #diabetes was associated with a slightly higher risk of developing….
0
9
0
@gcfmd
Gregg Fonarow MD
14 days
RT @drbennisahmed: Optimizing Medical Therapy Using Remote Monitoring and Artificial Intelligence in Patients With Heart Failure: The TURIN….
0
4
0
@gcfmd
Gregg Fonarow MD
18 days
RT @ankeetbhatt: Does timing of #GDMTworks affect economic value? In @JCardFail from #DELIVER, we examine #CostEffectiveness of #SGLT2i by….
0
7
0
@gcfmd
Gregg Fonarow MD
18 days
RT @MushoodCh: Our new publication in.@RPTHjournal !.🩸 Reduced-dose DOACs for extended #VTE treatment.⚖️ Similar efficacy to full-dose.🛡️ L….
0
7
0
@gcfmd
Gregg Fonarow MD
19 days
RT @drbennisahmed: Optimizing Medical Therapy Using Remote Monitoring and Artificial Intelligence in Patients With Heart Failure: The TURIN….
0
8
0
@gcfmd
Gregg Fonarow MD
19 days
RT @JTThibs: This is SO COOL! New in @JACCJournals #JACCHF: HF-AI software system that integrates HF guidelines & pt info improved GDMT usa….
0
18
0